Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARB/NEP Inhibition and Hypotensive Response
NCT03738878Phase 4Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2018
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sacubitril + valsartan in hypertension (HTN), sponsored by Vanderbilt University Medical Center. Started Nov 2018; status: terminated.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03738878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738878.